+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies



Role of glucotoxicity and lipotoxicity in the pathophysiology of Type 2 diabetes mellitus and emerging treatment strategies



Diabetic Medicine 26(12): 1185-1192



Type 2 diabetes mellitus is a disease characterized by persistent and progressive deterioration of glucose tolerance. Both insulin resistance and impaired insulin secretion contribute to development of Type 2 diabetes. However, whilst insulin resistance is fully apparent in the pre-diabetic condition, impairment of insulin secretion worsens over the time, being paralleled by a progressive decline in both pancreatic B-cell function and B-cell mass. Intense research has identified a number of genetic variants that may predispose to impaired B-cell function, but such predisposition can be precipitated and worsened by toxic effects of hyperglycaemia (glucotoxicity) and elevated levels of free fatty acids (lipotoxicity). All these aspects of the pathogenesis of Type 2 diabetes are discussed in this review. Moreover, treatments that target reduction in glucotoxicity or lipotoxicity are outlined, including emerging strategies that target the role of glucagon-like peptide 1 and sodium glucose co-transporter 2.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055605267

Download citation: RISBibTeXText

PMID: 20002468

DOI: 10.1111/j.1464-5491.2009.02847.x


Related references

Glucotoxicity and lipotoxicity: factors in the pathogenesis and evolution of type 2 diabetes. Revista Medica de Chile 129(6): 671-679, 2001

Lipotoxicity and glucotoxicity in type 2 diabetes. Effects on development and progression. Postgraduate Medicine 109(4): 55-9 63-4, 2001

Glucotoxicity and lipotoxicity, two implicated accomplices in the vicious circle of type 2 diabetes. Revue Medicale de Liege 54(6): 535-538, 1999

Progression from obesity to type 2 diabetes: lipotoxicity, glucotoxicity, and implications for management. Journal of Managed Care Pharmacy 11(6 Suppl B): S3, 2005

Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity. Endocrinology 143(2): 339-342, 2002

Emerging concepts in the pathophysiology of type 2 diabetes mellitus. Mount Sinai Journal of Medicine new York 76(3): 216-226, 2009

The emerging role of autophagy in the pathophysiology of diabetes mellitus. Autophagy 7(1): 2, 2011

Dissociation of lipotoxicity and glucotoxicity in a mouse model of obesity associated diabetes: role of forkhead box O1 (FOXO1) in glucose-induced beta cell failure. Diabetologia 54(3): 605-616, 2011

The role of pollutants in type 2 diabetes mellitus (T2DM) and their prospective impact on phytomedicinal treatment strategies. Environmental Monitoring and Assessment 190(5): 262, 2018

Glucotoxicity and beta-cell failure in type 2 diabetes mellitus. Journal of Pediatric Endocrinology & Metabolism 16(1): 5-22, 2003

Adipokine: Rolle in der Pathophysiologie und Therapie von Adipositas und Typ 2 Diabetes mellitus / Adipokines: Role in the pathophysiology and therapy of obesity and type 2 diabetes. Laboratoriums Medizin 33(1): 1-6, 2009

The physiology of glucagon-like peptide-1 and its role in the pathophysiology of type 2 diabetes mellitus. Medicina Clinica 143(Suppl. 2): 2-7, 2015

The physiology of glucagon-like peptide-1 and its role in the pathophysiology of type 2 diabetes mellitus. Medicina Clinica 143(Suppl. 2): 2-7, 2014

Continual evolution of type 2 diabetes: an update on pathophysiology and emerging treatment options. Therapeutics and Clinical Risk Management 11: 621-632, 2015

Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus. Endocrine 43(3): 504-513, 2013